Items where Division is "Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical/Medicinal Chemistry II (Prof. Buschauer)" and Year is 2000
![]() | Up a level |
A
Aiglstorfer, Iris and Hendrich, Ingo and Moser, Christiane and Bernhardt, Günther and Dove, Stefan and Buschauer, Armin (2000) Structure-activity relationships of neuropeptide YY1 receptor antagonists related to BIBP 3226. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 10 (14). pp. 1597-1600. ISSN 0960-894X
D
Dove, Stefan and Michel, M. C. and Knieps, S. and Buschauer, Armin (2000) Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide YY1 receptor antagonists. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 78 (2). pp. 108-115. ISSN 0008-4212, 1205-7541
G
Golob, Thomas and Biberger, Christian and Walter, Georg and von Angerer, Erwin (2000) Antiestrogenic activities of 3,8-dihydroxy-6,11-dihydrobenzo[a]carbazoles with sulfur-containing side chains. ARCHIV DER PHARMAZIE, 333 (9). pp. 305-311. ISSN 0365-6233
M
Moser, C. and Bernhardt, G. and Michel, J. and Schwarz, H. and Buschauer, Armin (2000) Cloning and functional expression of the hNPY Y-5 receptor in human endometrial cancer (HEC-1B) cells. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 78 (2). pp. 134-142. ISSN 0008-4212
S
Schlemmer, Richard and Spruss, Thilo and Bernhardt, Guenther and Schoenenberger, Helmut (2000) Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice. ARCHIV DER PHARMAZIE, 333 (12). pp. 397-403. ISSN 0365-6233
Z
Zabel, Manfred and Breu, Josef and Rau, Franz and Range, Klaus-Jürgen and Krey, Volker and Uffrecht, Anka and Buschauer, Armin (2000) Absolute configuration of (-)-4-(3,4-dichlorophenyl)-4-(2-pyridyl)butanoic acid: essential information to determine crucial steric features of arpromidine-type histamine H-2 receptor agonists. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 56 (2). pp. 250-251. ISSN 0108-2701

